COVID-19 vaccine protection may wane over time, according to new CDC data.

Spread the love

The three COVID-19 vaccines approved for use in the United States are much less effective against the Delta variant of the virus, but still protect against severe illness in most cases, according to data released Tuesday by the Centers for Disease Control and Prevention.

The vaccinations from Moderna, Pfizer-BioNTech, and Johnson & Johnson avoided serious illness from the virus in 91 percent of 4,200 front-line employees in eight U.S. cities before the Delta strain became the prevalent one locally, according to the statistics.

However, once the Delta variation became the most common strain of the virus in circulation in these areas, vaccine efficacy plummeted to 66%, according to the CDC.

“This trend should be interpreted with caution because vaccine efficacy might also be declining as time since vaccination increases,” the CDC researchers wrote.

Among those who were fully vaccinated — meaning they had received both shots of the two-dose Moderna and Pfizer-BioNTech vaccines or the one-shot Johnson & Johnson vaccine — protection peaked at 85% between 14 days and 119 days after inoculation.

READ ALSO:  Hurricane Sally lumbers toward U.S. Gulf Coast, threatens 'catastrophic flooding'

From 120 days to 149 after vaccination, protection fell to 81% before dropping to 73% 150 days or more following receipt of the vaccine.

The findings are based on an analysis of COVID-19 cases among 4,217 first responders, healthcare workers and others working in “essential” fields between December 2020 and Aug. 14.

Of the participants, nearly 3,500, or 83% were fully vaccinated, with 65% receiving the Pfizer-BioNTech shot, 33% given the Moderna shot and 2% getting the Johnson & Johnson shot.

Before the Delta variant emerged, there were 10 cases of COVID-19 infection among 2,875 fully vaccinated participants, and 175 cases among 4,137 unvaccinated participants.

However, after the Delta variant became dominant in circulation in the local areas of study participants, there were 24 confirmed COVID-19 cases among 2,352 fully vaccinated people and 19 cases among 488 unvaccinated people, the CDC said.

“Although these interim findings suggest a moderate reduction in the effectiveness of COVID-19 vaccines in preventing infection, the sustained two-thirds reduction in infection risk underscores the continued importance and benefits of COVID-19 vaccination,” the agency researchers wrote.

READ ALSO:  The United Kingdom has authorized the use of the Johnson & Johnson vaccination in COVID-19 patients. increase

The vaccinations from Moderna, Pfizer-BioNTech, and Johnson & Johnson avoided serious illness from the virus in 91 percent of 4,200 front-line employees in eight U.S. cities before the Delta strain became the prevalent one locally, according to the statistics.

However, once the Delta variation became the most common strain of the virus in circulation in these areas, vaccine efficacy plummeted to 66%, according to the CDC.

 

 203 

Leave a Reply